Static Chart StemRIM

Stocks

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-08-10 EDT			5-day change	1st Jan Change
326.00 ^JPY	+7.59%		+10.14%	+23.95%

07-22	Stemrim Announces Patent Registration in Mexico for Redasemtide as Therapeutic Agent for Cartilage Disorders	CI
07-08	StemRIM Inc. Announces Patent Registration For Stem Cell Gene Therapy Technology SR-GT1 Aimed At Curative Treatment Of Dystrophic Epidermolysis Bullosa In South Korea	CI

Duration

Period